Carregando...
Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study
OBJECTIVES: This study aimed to assess the efficacy of DA‐9701 on gastrointestinal symptom‐related quality of life in patients with Parkinson's disease on stable dopaminergic medications. METHODS: This multicenter, double‐blind, placebo‐controlled, phase 4 trial included a total of 144 patients...
Na minha lista:
| Publicado no: | Mov Disord |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754502/ https://ncbi.nlm.nih.gov/pubmed/32761955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.28219 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|